Lars Bullinger

Charité University Medicine

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (25)

Jesús María Hernández-Rivas

Universidad de Salamanca

SPAIN

View details

ROSA MARIA AYALA DIAZ

Full Professor

Universidad Complutense de Madrid

SPAIN

View details

Karl Haller

Charité - Universitätsmedizin Berlin

GERMANY

View details

Sofia Aakko

University of Helsinki

FINLAND

View details

Barbara Müller

PI/Prof.Dr.

University Hospital Heidelberg

GERMANY

View details

Olaf Penack

GERMANY

View details

Ulrich Keller

Prof. Dr.

Charité - Universitätsmedizin Berlin

GERMANY

View details

María Hernández-Sánchez

Profesor Ayudante Doctor

Universidad Complutense de Madrid Facultad de Medicina

SPAIN

View details

Nikolaj Frost

Charité Universitätsmedizin Berlin - Campus Virchow-Klinikum

GERMANY

View details

Frederik Damm

Charité - Universitätsmedizin Berlin

GERMANY

View details

Ulrik Kihlbom

Karolinska Institutet

SWEDEN

View details

Christian Meisel

GERMANY

View details

Lucie Loyal

Charité - Universitätsmedizin Berlin

GERMANY

View details

Jan Coburger

University Hospital Ulm

GERMANY

View details

Johannes Weller

University Hospital Bonn

GERMANY

View details

Mika Kontro

University of Helsinki

FINLAND

View details

Benedikt Obermayer

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

GERMANY

View details

Tommaso Araceli

University Hospital Regensburg

GERMANY

View details

Johann Ahn

Charité - Universitätsmedizin Berlin

GERMANY

View details

Professor Jonathan C Strefford

Professor of Molecular Oncology

University of Southampton

UNITED KINGDOM

View details

Eva Tranter

GERMANY

View details

Bob Löwenberg

NETHERLANDS

View details

Thomas Pabst

SWITZERLAND

View details

Il‐Kang Na

GERMANY

View details

Theophilos Tzaridis

Sanford Burnham Prebys Medical Discovery Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lars Bullinger

Research Interests

Explore related searches

Contact this professor

Articles (20)

Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients

Epidemiology of WHO grade 2 and grade 3 gliomas from 2009 to 2021 in Germany

A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agents.

Advanced disease and CD8+ TEMRA cells predict severe infections in multiple myeloma.

BEscreen: a versatile toolkit to design base editing libraries.

Growth Differentiation Factor-15: A Promising Biomarker and Target in Cancer Patients.

Leucine-rich α-2 glycoprotein 1 (LRG1) during inflammatory complications after allogeneic stem cell transplantation and CAR-T cell therapy.

New cardiovascular biomarkers in patients with advanced cancer - A prospective study comparing MR-proADM, MR-proANP, copeptin, high-sensitivity troponin T and NT-proBNP.

Practice Variation in Perioperative Dexamethasone Use and Outcomes in Brain Metastasis Resection.

Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance.

Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

Personalizing precision medicine: Patients with AML perceptions about treatment decisions.

Mechanisms of Resistance to Small Molecules in Acute Myeloid Leukemia

Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation.

Hand grip strength in patients with advanced cancer: A prospective study.

Patient-reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre-terminal cancer.

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use.

Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial.

Risk factors and characteristics influencing humoral response to COVID-19 vaccination in patients after allogeneic stem cell transplantation.

Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

Collaborators (25)

Jesús María Hernández-Rivas

ROSA MARIA AYALA DIAZ

Karl Haller

Sofia Aakko

Barbara Müller

Olaf Penack

Ulrich Keller

María Hernández-Sánchez

Nikolaj Frost

Frederik Damm

Ulrik Kihlbom

Christian Meisel

Lucie Loyal

Jan Coburger

Johannes Weller

Mika Kontro

Benedikt Obermayer

Tommaso Araceli

Johann Ahn

Professor Jonathan C Strefford

Eva Tranter

Bob Löwenberg

Thomas Pabst

Il‐Kang Na

Theophilos Tzaridis

Make your next move.